SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Deogan Charlotte L.)
 

Sökning: WFRF:(Deogan Charlotte L.) > A cost-effectivenes...

  • Deogan, Charlotte L.Karolinska Institutet (författare)

A cost-effectiveness analysis of the Chlamydia Monday A community-based intervention to decrease the prevalence of chlamydia in Sweden

  • Artikel/kapitelEngelska2010

Förlag, utgivningsår, omfång ...

  • 2010-01-11
  • SAGE PUBLICATIONS LTD,2010
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:mdh-50061
  • https://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-50061URI
  • https://doi.org/10.1177/1403494809357260DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:120095846URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Aims: The study was undertaken to assess the cost-effectiveness of the Chlamydia Monday, 2007. This is a community-based intervention aimed at reducing the prevalence of chlamydia by information and increased availability of testing, treatment and contact tracing in Stockholm. The aim was to analyze the cost-effectiveness by estimating costs, savings and effects on health associated with the intervention, and to determine if cost-effectiveness varies between men and women. Methods: A societal perspective was adopted, meaning all significant costs and consequences were taken into consideration, regardless of who experienced them. A cost-effectiveness model was constructed including costs of the intervention, savings due to avoiding potential costs associated with medical sequels of chlamydia infection, and health gains measured as quality adjusted life years (QALY). Sensitivity analyses were done to explore model and result uncertainty. Results: Total costs were calculated to be (sic)66,787.21; total savings to (sic)30,370.14; and total health gains to 9.852324 QALYs (undiscounted figures). The discounted cost per QALY was (sic)8,346.05 ((sic)10,810.77/QALY for women and (sic)6,085.35/QALY for men). Sensitivity analyses included changes in effectiveness, variation of prevalence, reduced risk of sequel progression, inclusion of prevented future production loss and shortened duration for chronic conditions. The cost per QALY was consistently less than (sic)50,000, which is often regarded as cost-effective in a Swedish context. Conclusions: The Chlamydia Monday has been demonstrated by this study to be a cost-effective intervention and should be considered a wise use of society's resources.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Bocangel, Marta K. HanssonStockholm Cty Council, Stockholm, Sweden. (författare)
  • Wamala, Sarah P. (författare)
  • Mansdotter, Anna M. (författare)
  • Karolinska InstitutetStockholm Cty Council, Stockholm, Sweden. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Scandinavian Journal of Public Health: SAGE PUBLICATIONS LTD38:2, s. 141-1501403-49481651-1905

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy